Skip to main content
OpenTrials

Clinical trial condition

Smallpox

Explore clinical trials studying Smallpox. Study availability and eligibility vary by location and protocol.

53 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Smallpox trial results

Completed

Lyophilized IMVAMUNE® (1x10^8 TCID50) Versus Liquid IMVAMUNE® (1x10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2x10^7 TCID50) Administered Intradermally

NCT00914732

Conditions
DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations
  • Emory Vaccine Center - The Hope Clinic Decatur, Georgia, United States
  • University of Iowa - Vaccine Research & Education Unit Iowa City, Iowa, United States
  • University of Maryland School of Medicine - Center for Vaccine Development - Baltimore Baltimore, Maryland, United States
  • Saint Louis University - Center for Vaccine Development St Louis, Missouri, United States
View Trial Details
Completed

Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection

NCT02038881

Conditions
DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Health for Life Clinic Little Rock Little Rock, Arkansas, United States
  • Quest Clinical Research San Francisco, California, United States
  • Dupont Circle Physicians Group Washington D.C., District of Columbia, United States
View Trial Details
Completed

A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects

NCT00857493

Conditions
DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations
  • Orlando Clinical Research Center Orlando, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
  • University of Kentucky, School of Medicine, Department of Medicine Lexington, Kentucky, United States
  • University of Rochester, Medical Center Rochester, New York, United States
View Trial Details
Completed

A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects

NCT01144637

Conditions
DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations
  • Alabama Vaccine Research Clinic Birmingham, Alabama, United States
  • Anaheim Clinical Trials Anaheim, California, United States
  • National Research Institute Los Angeles, California, United States
  • Northern California Clinical Research Center (NCCRC) Redding, California, United States
View all 34 locations
View Trial Details
Completed

Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®

NCT01827371

Conditions
DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations
  • Emory Vaccine Center - The Hope Clinic Decatur, Georgia, United States
  • University of Iowa - Vaccine Research and Education Unit Iowa City, Iowa, United States
  • University of Maryland Medical System - General Clinical Research Center (GCRC) Baltimore, Maryland, United States
  • Saint Louis University - Center for Vaccine Development St Louis, Missouri, United States
View Trial Details

Related conditions